Porcu L - Search Results

1

A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry.

Whisenant JG, Baena J, Cortellini A, Huang LC, Lo Russo G, Porcu L, Wong SK, Bestvina CM, Hellmann MD, Roca E, Rizvi H, Monnet I, Boudjemaa A, Rogado J, Pasello G, Leighl NB, Arrieta O, Aujayeb A, Batra U, Azzam AY, Unk M, Azab MA, Zhumagaliyeva AN, Gomez-Martin C, Blaquier JB, Geraedts E, Mountzios G, Serrano-Montero G, Reinmuth N, Coate L, Marmarelis M, Presley CJ, Hirsch FR, Garrido P, Khan H, Baggi A, Mascaux C, Halmos B, Ceresoli GL, Fidler MJ, Scotti V, Métivier AC, Falchero L, Felip E, Genova C, Mazieres J, Tapan U, Brahmer J, Bria E, Puri S, Popat S, Reckamp KL, Morgillo F, Nadal E, Mazzoni F, Agustoni F, Bar J, Grosso F, Avrillon V, Patel JD, Gomes F, Ibrahim E, Trama A, Bettini AC, Barlesi F, Dingemans AM, Wakelee H, Peters S, Horn L, Garassino MC, Torri V; TERAVOLT study group. Whisenant JG, et al. Among authors: porcu l. J Thorac Oncol. 2022 May;17(5):661-674. doi: 10.1016/j.jtho.2021.12.015. Epub 2022 Feb 1. J Thorac Oncol. 2022. PMID: 35121086 Free PMC article.

2

DNA-damage response gene polymorphisms and therapeutic outcomes in ovarian cancer.

Caiola E, Porcu L, Fruscio R, Giuliani D, Milani R, Torri V, Broggini M, Marabese M. Caiola E, et al. Among authors: porcu l. Pharmacogenomics J. 2013 Apr;13(2):159-72. doi: 10.1038/tpj.2011.50. Epub 2011 Dec 13. Pharmacogenomics J. 2013. PMID: 22158331

3

ALDH enzymatic activity and CD133 positivity and response to chemotherapy in ovarian cancer patients.

Ricci F, Bernasconi S, Porcu L, Erba E, Panini N, Fruscio R, Sina F, Torri V, Broggini M, Damia G. Ricci F, et al. Among authors: porcu l. Am J Cancer Res. 2013 Apr 3;3(2):221-9. Print 2013. Am J Cancer Res. 2013. PMID: 23593543 Free PMC article.

4

The impact of personalized medicine on survival: comparisons of results in metastatic breast, colorectal and non-small-cell lung cancers.

Rossi A, Torri V, Garassino MC, Porcu L, Galetta D. Rossi A, et al. Among authors: porcu l. Cancer Treat Rev. 2014 May;40(4):485-94. doi: 10.1016/j.ctrv.2013.09.012. Epub 2013 Sep 25. Cancer Treat Rev. 2014. PMID: 24112813 Review.

5

Clinical outcome of HER2-positive breast cancer patients after failure on adjuvant trastuzumab: the potential of the time to relapse.

Di Cosimo S, Serpico D, Porcu L, Molino L, Fanetti G, Torri V, de Braud F. Di Cosimo S, et al. Among authors: porcu l. Clin Oncol (R Coll Radiol). 2014 Mar;26(3):174. doi: 10.1016/j.clon.2013.11.028. Epub 2013 Dec 22. Clin Oncol (R Coll Radiol). 2014. PMID: 24368057 No abstract available.

6

Does surgery improve survival of patients with malignant pleural mesothelioma?: a multicenter retrospective analysis of 1365 consecutive patients.

Bovolato P, Casadio C, Billè A, Ardissone F, Santambrogio L, Ratto GB, Garofalo G, Bedini AV, Garassino M, Porcu L, Torri V, Pastorino U. Bovolato P, et al. Among authors: porcu l. J Thorac Oncol. 2014 Mar;9(3):390-6. doi: 10.1097/JTO.0000000000000064. J Thorac Oncol. 2014. PMID: 24518090 Free article.

7

Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.

Califano R, Karamouzis MV, Banerjee S, de Azambuja E, Guarneri V, Hutka M, Jordan K, Kamposioras K, Martinelli E, Corral J, Postel-Vinay S, Preusser M, Porcu L, Torri V. Califano R, et al. Among authors: porcu l. Lung Cancer. 2014 Jul;85(1):74-80. doi: 10.1016/j.lungcan.2014.03.010. Epub 2014 Mar 16. Lung Cancer. 2014. PMID: 24746176

8

Sequential Tyrosine Kinase Inhibitors (TKIs) in metastatic renal cell carcinoma: results from a large cohort of patients.

Biondani P, Verzoni E, Torri V, Porcu L, Grassi P, Testa I, DE Braud F, Procopio G. Biondani P, et al. Among authors: porcu l. Anticancer Res. 2014 May;34(5):2395-8. Anticancer Res. 2014. PMID: 24778049 Free article.

9

Targeted therapies in advanced renal cell carcinoma: the role of metastatic sites as a prognostic factor.

Grassi P, Verzoni E, Porcu L, Testa I, Iacovelli R, Torri V, Braud Fd, Procopio G. Grassi P, et al. Among authors: porcu l. Future Oncol. 2014 Jun;10(8):1361-72. doi: 10.2217/fon.14.69. Future Oncol. 2014. PMID: 25052747

10

Oral prevalence and clearance of oncogenic human papilloma virus in a rehabilitation community for substance abusers in Italy: a case of behavioral correction?

Pugliese DB, Bruzzesi G, Montaldo C, Porcu L, Landi M, Mastinu A, Torri V, Licitra L, Locati LD. Pugliese DB, et al. Among authors: porcu l. J Oral Pathol Med. 2015 Oct;44(9):728-33. doi: 10.1111/jop.12291. Epub 2014 Nov 17. J Oral Pathol Med. 2015. PMID: 25401955

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters